Latest close: a new 52-week highSep 8, 2026what changed →
Is the price fair?
What CLMT's price assumes
Calumet, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 0.75× revenue.
0.75
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 1.27
EV / sales
Details›
- EV / EBIToperating margin −0.33%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q1
- 1.27
- Market capitalisation
- $2.99B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #3 of 27 by Smart Score